share_log
Benzinga ·  Aug 20 16:30
Shares of Diabetes-related Stocks Closed Lower Following Data From Lilly Showing Weekly Tirzepatide Injections Reduced the Risk of Progression to Type 2 Diabetes by 94% in Adults With Pre-diabetes and Obesity
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment